Novel seaweed extracts: Cancer-inhibiting properties discovered in fucoidans

a32ef9ca-eee1-43d1-937f-1d92ee7492bfarticleimage.jpg

05 Dec 2017 --- Breakthrough research has confirmed that two unique compounds extracted from a specific seaweed have significant cancer-inhibiting properties. A series of animal studies undertaken at McGovern Medical School, University of Texas Health Science Center in Houston (UTHealth) have shown that the two fucoidans reduced tumor growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen.

For centuries, fucoidan-containing seaweeds have been prized for their dietary and therapeutic properties. Their medicinal properties have been particularly well documented in Asian cultures, where seaweeds have been used to address health conditions that range from nausea, congestion and inflammation through to abscesses and tumors. Despite this long history of seaweeds as medicinal agents, it was not until the 20th century that fucoidan was first isolated and recognized for its therapeutic potential.

“Seaweed has been used in Asian markets for centuries for its healing properties, where it is being used in supplements, cosmetics and functional foods. But it is growing quite a lot in America and Europe, especially in supplements and in immune, joint health and anti-cancer applications,” Claire Smoorenburg, Science Communications at fucoidan ingredients supplier Marinova, tells NutritionInsight.

The new cancer-related findings also come at a time when the nutritional potential of seaweed extracts seems to be entering a new phase of recognition. Number 9 on Innova Market Insights’ list of top trends for 2018 is “Ocean Garden,” with the organization explaining that “nutrient-dense vegetables from the sea, like kelp and spirulina, are finding their way into a wider variety of new food and beverage products due to their ability to provide nutritional fortification, act as a natural source of color and deliver unique flavors, especially umami.”

Fucoidan’s potential to complement chemotherapy
The new cancer breakthrough demonstrates the potential for fucoidan to be safely used as a complementary cancer therapy alongside traditional chemotherapy, Marinova reports.

The extracts, developed and manufactured by Marinova, were tested in six human tumor mouse models, including cervical, breast and ovarian cancers. Fucoidan extracts were orally administered to mice for 30 days and compared to controls.

Ingestion of the fucoidan extracts decreased the growth of a human ovarian cancer tumor line by up to 33 percent and a human cervical cancer tumor line by up to 70 percent.

The same breast and ovarian cancer models were also used to assess fucoidan activity in combination with paclitaxel or tamoxifen, two commonly used chemotherapy agents. The results showed that fucoidan considerably improved the efficacy of tamoxifen towards breast cancer. Fucoidan decreased breast cancer tumor growth in this animal model by up to an additional 26 percent when taken alongside tamoxifen.

These findings build on results from a series of in vitro studies performed under the same research program. The in vitro studies showed that the two fucoidan extracts did not interfere with key metabolic pathways necessary for chemotherapy function and directly inhibited a number of human cancer cell lines. Strong synergistic activity between fucoidan and both paclitaxel and tamoxifen was also observed, as well as additive activity with topotecan.

“This was the first research program to comprehensively assess the metabolism of fucoidan compounds for possible chemotherapy drug interactions,” comments Associate Professor Dr. Judith A. Smith, Director of the Women’s Health Integrative Medicine Research Program at UTHealth, who led the research project.

“A pharmacokinetic study is now underway at UTHealth to further assess safety and observe quality of life parameters in human cancer patients,” Dr. Smith adds.

Adding to these findings, a further study in the research program found that both fucoidan extracts enhanced the immune function of cancer-affected mice. Immune markers immunoglobulin G (IgG) and interleukin 6 (IL-6) were both significantly modulated in fucoidan-fed mice, with a 500 percent increase in IgG levels relative to controls after one week.

IgG is the main type of antibody found in humans. It helps control infections by binding to pathogens (such as bacteria and viruses) and alerting circulating immune cells. IgG levels are often suppressed in oncology patients, making them vulnerable to a wide range of infections.

“These results confirm the potential for fucoidan to help restore functional immunity in cancer patients,” comments Dr. Helen Fitton, Chief Scientist at Marinova, highlighting the importance of these findings. “To have identified a safe, natural compound that has such a significant effect on immunity in an oncology setting is really quite remarkable.”

The two clinical studies have been published in the journal Integrative Cancer Therapies: “Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models” and “Pre-clinical evaluation of safety of fucoidan from Undaria pinnatifida and Fucus vesiculosus for use by oncology patients.”

Marinova continues to back up its products’ benefits, as its Maritech fucoidan extracts recently attained GRAS (Generally Recognized As Safe) status. Australian researchers have also worked with Marinova on using seaweed to heal brain injuries NutritionInsight caught up with Smoorenburg at VitaFoods Asia 2017, where she mentioned the then-ongoing chemotherapy research along with other topics. “I think it has a lot of potential in pharmaceuticals, as well as medical devices, which are on the rise in Europe,” Smoorenburg added of fucoidan.

By Paul Creasy

Related Articles

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

Vegan diet improves diabetes markers in overweight adults: study

16 Feb 2018 --- A plant-based diet improves beta-cell function and insulin sensitivity in overweight adults with no history of diabetes, according to a new study published in Nutrients by researchers from the Physicians Committee for Responsible Medicine. Measuring the function of beta cells, which store and release insulin, can help assess future type 2 diabetes risk.

Nutrition & Health News

Ultra-processed foods linked to heightened risk of cancer: major BMJ study

15 Feb 2018 --- Although processed foods have long been thought to be significantly less healthy than non-processed foods, an observational study published yesterday in BMJ has added some stark figures to the link between ultra-processed foods and the risk of cancer. The study concluded that a 10 percent increase in the proportion of ultra-processed foods in the diet is associated with increases of 12 percent in the risk of overall cancer and 11 percent in the risk of breast cancer.

Nutrition & Health News

Plant-based foods could slash a country’s healthcare costs by billions of euros, says study

15 Feb 2018 --- Billions of euros could be saved from a country’s annual healthcare bill over the next years if more people followed a plant-based diet. This is according to a new study published in the Journal of Nutrition which looked at the health and economic consequences of two plant-based eating patterns, a diet with a daily portion of soy foods and a Mediterranean-style diet.

Nutrition & Health News

Saturated fat and sugar can cause depression and anxiety: study

14 Feb 2018 --- A diet rich in saturated fat, such as palm oil, and sugar not only leads to obesity, but it also creates inflammation in the nucleus accumbens, a part of the brain that controls mood and the feeling of reward. This inflammation can lead to depressive, anxious and compulsive behavior and disrupt metabolism, according to a study from the University of Montreal Hospital Research Centre (CRCHUM). The discovery illustrates the vicious circle experienced by people with obesity caused by a diet rich in sugar and saturated fat, with their diet leading to negative emotions, which can stimulate the quest for more comfort through food.

More Articles
URL : http://www.nutritioninsight.com:80/news/novel-seaweed-extracts-cancer-inhibiting-properties-discovered-in-fucoidans.html